Immunotech Laborator (CE) (IMMB) Share Price

Guessing we have lost our money on IMMB?
I would love someone to explain in simple layman terms what happened, if so.

“Enzolytics wants to inform its shareholders that the ownership of the Company's patented technology is held exclusively in the name of The Zhabilov Trust, with Diana Zhabilov serving as the trustee of the trust.”

The ENZC board has to be pissed after all the explanation to the Zhabilov Trust and what it contains, they(ENZC board) though Enzolytics Inc. owned ITV-1 through 4.

Right, shenanigans.

19. In sum, Mr. Savov’s motion for judgment on the pleadings is GRANTED as to Counts I and III. Accordingly, Counts I and III are DISMISSED WITH PREJUDICE. Although I lack equitable jurisdiction over Counts IV and V, the Company may elect to transfer them to a Delaware court of law. See 10 Del. C. § 1902.11 Finally, Count II is DISMISSED as MOOT.

I think you know what this pertains to, enjoy.

And if you don’t…

https://courts.delaware.gov/Opinions/Download.aspx?id=345220

Harry give him his shares.

“18. Separately and finally, Count II sought to block a stock transfer that was set to occur “on the 31st day after September 2, 2021.” Dkt. 20 ¶ 44. So Count II is moot. Because mootness is a question of subject matter jurisdiction,8 and the Company has not alleged facts suggesting that a transfer completed more than a year ago is “capable of repetition, but evad[ing] review,”9 I dismiss Count II sua sponte.10”

Don’t know if you are still around, after all this clowning around. “Company” is cited as Enzolytics.

“I . . . have significant concerns about entering an ex parte TRO here, where I have almost no information about the obligations that the [Company] says were violated, whether Delaware law applies, and so forth. Frankly, I’m left more confused after today’s call about the nature of the claim here and where Mr. Savov’s obligations were created . . . .
[Company] counsel should continue to update me on efforts to serve Mr. Savov . . . . But if that happens, [the Company will] need to show me . . . what the claims are. And for now, that seems to be a hurdle for the [Company].”

https://courts.delaware.gov/Opinions/Download.aspx?id=345220

Language in both are consistent.

https://www.immunh.com/specialistsen

https://enzolytics.com/enzolytics-inc-intellectual-property/

Updated at the bottom, 2022.

Possible Distributor overseas for the African communities?!?!
Previous approval in the BDA, makes for fast tracking logistics and product readiness.
Since Bulgaria is part of the EU, it would make sense for Immunotech Laboratories BG to fast track the testing and labs.

I'm looking at it right now, it didn't get deleted. However, been watching your shenanigans for a minute.

I posted this on the ENZC board, but like everything else I post there it gets removed.

This is the shadest Current presentation I have ever seen, first off, Adequate?!?! What’s adequate? There is no data to signal a sigh of relief. But then again it is a penny stock.

ENZOLYTICS INC. in regards to being current.

https://www.otcmarkets.com/otcapi/company/financial-report/330433/content

The lawyer that signed this already has a bad rap with the SEC, nice move.

https://www.sec.gov/litigation/complaints/2011/comp21808.pdf

Short answer, maybe. 50/50 chance.

As long as they can start generating revenue for Enzolytics Inc.. But in order to generate revenue you have to have a good business plan. I have not seen the directive or a future looking statement to ease investors worries. After all this is a penny play information is very little and all cylinders don’t have to fire in order to trade on the OTC.

But the take away here is generating revenue. Especially for this ticker.

Anyone know the chances of us getting our money back on this one?

IMMB share structure

Sorry. Didn’t know if I pointed you in the right direction or if you noticed the updated share breakdowns.

It was under Security Details.

Everything else is current except for the float.

And we know what a float can do to a company if it is too large.

That would be interesting. Then we find out what's under the hood. Probably a lot more than $0.001 per share, imo.

It looks as if though your wish is coming true.

https://www.otcmarkets.com/stock/IMMB/research

OTC is getting updated.

When is the paperwork coming?

Somebody needs to do a custo on this and put a rocket in Harry's pocket. What is he hiding about the value?

Wanting to remove Savov from a seat on the voting seems to be the end game.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166115301

I wonder then if ENZC is the sole manufacturer of ITV-1.

Why is Harry updating/bringing current some IMMB docs?!?!

Then the bigger question, what is the $6million payout to IMMB for?

Enzolytics paid IMMB $3 million in 2020 and $3 million in 2021, need clarity on that money.

Was it the buyout of IMMB or all of IMMB’s assets.

And who got that money?

Maybe the reason why Savov is upset.

Says they are currently producing ITV-1 out of the Texas A&M Lab.

https://enzolytics.com/company-news/

https://www.nbcnews.com/news/us-news/tennessee-limiting-monoclonal-antibody-treatment-unvaccinated-residents-n1279740

Well that nixes Eli Lilly and Regeneron from buying Enzolytics Inc..

But $2100 for Monoclonal, wow!

Which big name pharma wants a piece of the pie?!?!

P.S. Enzolytics being very hush hush for so long only throws one thought on the table their is an NDA in their office.

Possible. Or just to stave off a custodianship. Either way, shareholders win however it gets curret.

Just food for thought.

What if Harry is becoming current with IMMB, due to ENZC being bought out?!?!

Harry knows the potential with the price per Dimitar's value stated from your post off of Facebook.

And if IMMB is the sole provider/producer of ITV-1, he just stands to make himself richer yet.

Thanks for posting this. Makes things clearer.

Any shareholder can petition the court for custodianship, so that is another path, one that might light a fire under Harry's butt if he thinks he will lose control and the true assets of $IMMB will be revealed. That may already be a growing fear. He recently filed a Certificate of Restatement in Nevada, so something has his attention.

If Dimitar is right in regard of his value of ITV-1, then there is value in IMMB. But to bring IMMB current, one of four things need to happen, voting out HZ as CEO and then electing a new CEO,
finding a reputable accounting firm that will require some money to back track all those years and then a lawyer to stamp it all. Time line, about a year for this all to get done. Unless you have the funds to make it sooner.

This will be very interesting to see how this unfolds.

Meanwhile, Dimitar is organizing shareholders to bring $IMMB current.

From the Immunotech Laboratories BG Facebook page:

TO THE SHAREHOLDERS OF IMMUNOTECH LABORATORIES INC. (IMMB)
Dear shareholders in Immunotech Laboratories Inc. (IMMB),
For more than 5 years, the CEO of IMMB, Harry Zhabilov, has not organized the mandatory yearly shareholders meetings, has not made yearly balances of the company and has not conducted an audit of the company on purpose. I, Dimitar Savov, who own more than 15% in IMMB and am a majority shareholder in Immunotech Laboratories BG, believe that Zhabilov is purposefully leading IMMB towards bankruptcy in order to transfer its assets to a different company where he has more shares. All of us, the shareholders in IMMB, must unite and conduct a yearly shareholder meeting in order to elect a new board of directors. IMMB has an immense potential for profit and dividends, because the company owns 49% in Immunotech Laboratories BG; this means that IMMB will receive 49% of the profits from the sale of ITV-1, a medicinal product, which we have clinically tested for AIDS in Bulgaria (EU) and has shown very good treatment effect. Immunotech Laboratories BG has signed long-term agreements with many big partners for the sale of millions of sets of ITV-1 for countries like Ukraine, Greece, Romania, Turkey, and others. The average profit per set of ITV-1 will be 1500 EUR, which means profits in billions.
I ask for all shareholders in IMMB to contact us on immunotechlabsbg@gmail.com so we can coordinate our actions and bring IMMB to current status.
With respect,
Dimitar Savov
President of Immunotech Laboratories BG

Too much money wrapped up into the “Lab” that was suppose to be producing ImmunH(ITV-1).

Had to make it worth while his adventure(because of the amount of shares HZ has) and the availability/readiness of the Bulgarian Lab(although I don’t think it’s actually in Bulgaria, or is it?!?!).

Major overhaul on the website:
https://www.immunotechlaboratoriesbg.com/information-for-specialists

And I noticed here too:
https://www.otcmarkets.com/stock/IMMB/profile

You can try through the transfer agent, but there is no guarantee.

GL

Who can I buy this stock with E*TRADE want let me.

.

Somebody wants everybody's shares. Look at the ridiculous tape painting going on.

Isn’t it crazy to want Dimitri’s shares but at the same time pay him $3 million in 2020 and in 2021?!?!

Something smells fishy.

Dimitri is on the hot seat.

https://backend.otcmarkets.com/otcapi/company/financial-report/297979/content

“On July 15, 2021, an action was commenced against Dimitri Savov, a resident of Sofia, Bulgaria, in the Court of Chancery of the State of Delaware seeking a temporary restraining order, injunctive relief, a declaratory judgment and damages arising from illegitimate and false claims made by Mr. Savov regarding his purported ownership of stock in the Company. Additionally, Mr. Savov has made numerous defamatory statements about the Company and its Directors. These actions by Mr. Savov damaged the Company and constitute tortious interference with the Company’s current and prospective business relationships. The Company intends to pursue all available claims and remedies against Mr. Savov to the fullest extent permitted under the law and is in the process of filing a criminal complaint against Mr. Savov in Bulgaria. As 49% owner of IMMB BG, Enzolytics has assisted with the filing of forgery and fraud charges against Mr. Savov in Sofia earlier in the second quarter as well. The Company is working to mitigate the damages caused by Mr. Savov to relationships recently announced between the Company and other entities.“

Maybe I am off, but wasn’t there an SEC document showing IMMB 49% owner of ENZC?

He probably has an argument to fight back the claims in regard of Harry Zhabilov’s negotiations.

Who knows.

GLTA

It will be interesting who(possible insider purchase) pulled the string on the 1.6million share purchase. Knowing that Immunotech Laboratories, Inc.(IMMB) is still going to be the supplier for Enzolytics Inc.. Like you said transparency is coming, just excited to see how wrong I am with all my predictions

Looks like someone accumulating shares quietly. Guessing Harry will have to get the filings up to date or deal with a shareholders meeting. Either way, we get transparency.

Ah, making sense. I see they are trying to build a network with a Parent company.

Parent Company = Enzolytics Inc.(ENZC)

The daughter companies below working on specific drugs or the manufacturing of specific drugs

Immunotech Laboratories, Inc.(IMMB), manufacturing ITV 1-4
BioClonetics Immunotherapy, Inc., producing the Clone3
Biogenysis, Inc., whatever they do yada yada yada
Virogentics, Inc., whatever they do yada yada yada
ENZC Sub., Inc., whatever they do yada yada yada

Building value. If I am wrong, I stand to be corrected.

The address listed for the Enzolytics Inc. Quarterly extension June 30, 2021:

120 W. Pomona Ave
Monrovia, California
91016

Is listed for sale, ha, https://www.bhhscalifornia.com/listing-detail/120-w-pomona-avenue-monrovia-ca-91016_4542670

It is the same address that IMMB uses.

https://backend.otcmarkets.com/otcapi/company/financial-report/165975/content

After all these years you think there would have been some separation between the two, hmmm.

Harry doesn't want to let go of those shares.

B. Please list any subsidiaries, parents, or affiliated companies.
The Company is a 49% owner of the Bulgarian entity IMMB BG, which holds a sub-license agreement issued by ENZC for the proprietary immunotherapy treatment.
The Company is 100% owner of Biogenysis, Inc.
The Company is 100% owner of Virogentics, Inc.
The Company is 100% owner of ENZC Sub., Inc.
The Company is 100% owner of BioClonetics Immunotherapy, Inc.

Well, sub license agreement. Still tied to them.

ENZC is filing to be upgraded to QB. And it has to be relatively close, so I am assuming that Harry is finally addressing IMMB’s status.

A lot of shadows need to be lit about what $IMMB owns. It's either the IP, or a big block of $ENZC stock from the IP transfer, if it it ever happened, as far as I can tell. But Harry has definitely been keeping us in the dark. Filings are highly welcome.

So we are rich now?


ITV-1 still immb’s IP and ceo trying to hide it by not filing.


This will be confirmed by filings?

Found the Certificate of Reinstatement on the Nevada SOS site. Thanks.

Good to know. But nothing on OTC or EDGAR yet. Probably preferable to "some" than a shareholder takeover or custodianship.

Filed for reinstatement

Check out Immunotech Laboratories BG's Facebook page. Looks like Dimitar (15% owner) is trying to organize a shareholders meeting to address the lack of transparency and filings.

Interesting!

$IMMB woke up. What's up? Harry suddenly going to update filings? Custodianship?

This ticker is a great candidate for a custodianship. Look at what happened to $LLBO.

https://finance.yahoo.com/news/curative-biotechnology-inc-files-2021-135000170.html

Dimiter Dimitrov, Ph.D.

This guy is light years ahead of Harry in this industry. Charles looks to be getting there but Harry's messy past maybe taking longer than it should have. Since Harry's smear from the Ebola "mis-information" in Africa, Charles may have to clean up verbiage(a lot of it) to rectify that Enzolytics Inc. is developing a viable product for the bio-tech world.

Granted Dimiter's medicines in development is a different path than Harry's, but much further ahead. They(Curative Biotech) look to be better organized and goal oriented.

Enzolytics Inc. maybe headed down a path but direction is unclear and not specific to investors. Organized, something is missing in Enzolytics mission statement to how the team will achieve through the path.

When Enzolytics Inc. has their ducks in a row, their "unknown" contractor(IMMB) will start producing the compounds ITV1-4 and generating revenue both in a wholistic therapy for over the counter and medicinal compound for treating viruses and diseases. This should garner enough for generating revenue.

IMMB getting current- Harry has to get IMMB current, if he wants to see value($). Granted he doesn't have to abide by a lot of the rules under a PENNY stock. But if he is looking to turn a profit on his venture with IMMB that is in "control"(speculation) of ENZC. Pink Current has to be at the fore front. If he cares only about curing the world and not so much money, then we are all SOL.

This information is only for the intent of IMMB investors and this information is only speculatively driven based on all present information to date.

TDA to stop trading CE stocks later this month. Other retail brokers likely to follow. Custodianship may be the only way for shareholders to extract their value unless Harry quits playing hide the ball with the assets.